Skip to content

National Health Investors, Inc.: 10-K filed 2020-02-19

What National Health Investors, Inc. reported in its annual report filed 2020-02-19 (fiscal FY 2019): 28 published measures, 127 facts as tagged in accession 0000877860-20-000018.

This filing

Form
10-K (annual report)
Filed
2020-02-19
Fiscal period
fiscal FY 2019
Accession
0000877860-20-000018 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All National Health Investors, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-12-313,042,235,000USD
At 2018-12-312,750,570,000USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-12-311,543,983,000USD
At 2018-12-311,360,857,000USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-12-311,497,631,000USD
At 2018-12-311,389,713,000USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-12-315,215,000USD
At 2018-12-314,659,000USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-10-01 to 2019-12-3142,040,000USD92
2019-01-01 to 2019-12-31160,456,000USD365
2019-07-01 to 2019-09-3042,758,000USD92
2019-04-01 to 2019-06-3039,979,000USD91
2019-01-01 to 2019-03-3135,679,000USD90
2018-10-01 to 2018-12-3137,083,000USD92
2018-01-01 to 2018-12-31154,333,000USD365
2018-07-01 to 2018-09-3040,979,000USD92
2018-04-01 to 2018-06-3037,839,000USD91
2018-01-01 to 2018-03-3138,432,000USD90
2017-01-01 to 2017-12-31159,365,000USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-01-01 to 2019-12-31240,955,000USD365
2018-01-01 to 2018-12-31207,869,000USD365
2017-01-01 to 2017-12-31198,095,000USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-01-01 to 2019-12-31237,186,000USD365
2018-01-01 to 2018-12-31147,645,000USD365
2017-01-01 to 2017-12-31175,793,000USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-10-01 to 2019-12-3182,196,000USD92
2019-01-01 to 2019-12-31318,081,000USD365
2019-07-01 to 2019-09-3081,682,000USD92
2019-04-01 to 2019-06-3078,096,000USD91
2019-01-01 to 2019-03-3176,107,000USD90
2018-10-01 to 2018-12-3173,995,000USD92
2018-01-01 to 2018-12-31294,612,000USD365
2018-07-01 to 2018-09-3074,915,000USD92
2018-04-01 to 2018-06-3072,956,000USD91
2018-01-01 to 2018-03-3172,746,000USD90
2017-01-01 to 2017-12-31278,659,000USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-01-01 to 2019-12-31107,323,000USD365
2018-01-01 to 2018-12-3144,258,000USD365
2017-01-01 to 2017-12-31-35,052,000USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-01-01 to 2019-12-31-342,521,000USD365
2018-01-01 to 2018-12-31-250,290,000USD365
2017-01-01 to 2017-12-31-163,846,000USD365

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-10-01 to 2019-12-3144,107,770shares92
2019-01-01 to 2019-12-3143,417,828shares365
2019-07-01 to 2019-09-3043,505,332shares92
2019-04-01 to 2019-06-3043,232,384shares91
2019-01-01 to 2019-03-3142,825,824shares90
2018-10-01 to 2018-12-3142,351,443shares92
2018-01-01 to 2018-12-3141,943,873shares365
2018-07-01 to 2018-09-3042,187,077shares92
2018-04-01 to 2018-06-3041,704,819shares91
2018-01-01 to 2018-03-3141,532,154shares90
2017-01-01 to 2017-12-3140,894,219shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2019-10-01 to 2019-12-3144,328,847shares92
2019-01-01 to 2019-12-3143,703,248shares365
2019-07-01 to 2019-09-3043,861,089shares92
2019-04-01 to 2019-06-3043,498,021shares91
2019-01-01 to 2019-03-3143,125,032shares90
2018-10-01 to 2018-12-3142,568,720shares92
2018-01-01 to 2018-12-3142,091,731shares365
2018-07-01 to 2018-09-3042,434,499shares92
2018-04-01 to 2018-06-3041,786,829shares91
2018-01-01 to 2018-03-3141,576,876shares90
2017-01-01 to 2017-12-3141,151,453shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-10-01 to 2019-12-310.95USD/shares92
2019-01-01 to 2019-12-313.7USD/shares365
2019-07-01 to 2019-09-300.98USD/shares92
2019-04-01 to 2019-06-300.92USD/shares91
2019-01-01 to 2019-03-310.83USD/shares90
2018-10-01 to 2018-12-310.88USD/shares92
2018-01-01 to 2018-12-313.68USD/shares365
2018-07-01 to 2018-09-300.97USD/shares92
2018-04-01 to 2018-06-300.91USD/shares91
2018-01-01 to 2018-03-310.93USD/shares90
2017-01-01 to 2017-12-313.9USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2019-10-01 to 2019-12-310.95USD/shares92
2019-01-01 to 2019-12-313.67USD/shares365
2019-07-01 to 2019-09-300.97USD/shares92
2019-04-01 to 2019-06-300.92USD/shares91
2019-01-01 to 2019-03-310.83USD/shares90
2018-10-01 to 2018-12-310.87USD/shares92
2018-01-01 to 2018-12-313.67USD/shares365
2018-07-01 to 2018-09-300.97USD/shares92
2018-04-01 to 2018-06-300.91USD/shares91
2018-01-01 to 2018-03-310.92USD/shares90
2017-01-01 to 2017-12-313.87USD/shares365

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-01-01 to 2019-12-3156,299,000USD365
2018-01-01 to 2018-12-3149,055,000USD365
2017-01-01 to 2017-12-3146,324,000USD365

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2019-12-313,212,000USD
At 2018-12-316,381,000USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-01-01 to 2019-12-31156,809,000USD365
2018-01-01 to 2018-12-31139,541,000USD365
2017-01-01 to 2017-12-31127,168,000USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-12-3144,587,486shares
At 2018-12-3142,700,411shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2019-12-3115,669,000USD
At 2018-12-319,912,000USD
At 2017-12-318,075,000USD
At 2016-12-318,878,000USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-12-31-3,432,000USD
At 2018-12-311,299,000USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2019-12-311,498,252,000USD
At 2018-12-311,389,713,000USD
At 2017-12-311,322,117,000USD
At 2016-12-311,209,590,000USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2019-01-01 to 2019-12-31161,272,000USD365
2018-01-01 to 2018-12-31155,071,000USD365
2017-01-01 to 2017-12-31151,491,000USD365

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-01-01 to 2019-12-31160,449,000USD365
2018-01-01 to 2018-12-31154,333,000USD365
2017-01-01 to 2017-12-31159,365,000USD365

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-01-01 to 2019-12-31155,725,000USD365
2018-01-01 to 2018-12-31156,219,000USD365
2017-01-01 to 2017-12-31152,812,000USD365

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-01-01 to 2019-12-3113,399,000USD365
2018-01-01 to 2018-12-3112,547,000USD365
2017-01-01 to 2017-12-3112,217,000USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-01-01 to 2019-12-3176,816,000USD365
2018-01-01 to 2018-12-3171,349,000USD365
2017-01-01 to 2017-12-3167,173,000USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2019-01-01 to 2019-12-3154,027,000USD365
2018-01-01 to 2018-12-3145,882,000USD365
2017-01-01 to 2017-12-3143,191,000USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-01-01 to 2019-12-3195,774,000USD365
2018-01-01 to 2018-12-3181,784,000USD365
2017-01-01 to 2017-12-31122,237,000USD365

Inspect the source

Entity
National Health Investors, Inc. / CIK 0000877860
Captured
2026-09-20T05:01:19.323Z
SEC response SHA-256
800d4eb06d8d005c13461b54ffacc4cde98eabd76680f56a43c825e171984500

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000877860.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))